Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-003978
Filing Date
2025-06-11
Accepted
2025-06-11 10:06:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2932
  Complete submission text file 0001959173-25-003978.txt   4442
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Subject) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38753 | Film No.: 251038957
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Hussain Abbas (Reporting) CIK: 0001821956 (see all company filings)

Type: 144